Back to Top
Abelacimab Biosimilar - Research Grade
$710.00 - $6,900.00
Abelacimab Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
F11ï؟½
Concentration
5mg/ml
Isotype
IgG1 - lambda2
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Uniprot
P03951
Shipping Conditions
Blue ice
Background
Coagulation factor XI (F11) is a serine protease zymogen of the intrinsic pathway and an emerging target in thrombosis research that aims to separate clotting from haemostasis. This anti-human factor XI recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of abelacimab, provided strictly for research use only. Built to rigorous in vivo standards with low endotoxin, it is manufactured in scalable milligram (mg) to gram (g) quantities for bulk and high-throughput laboratories. It serves as a consistent inhibitory control and active reagent in coagulation assays, in vitro functional screening, and in vivo thrombosis models.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review












